Preparation & Measurement Guide
Tirzepatide 40mg Dosage Protocol
Preparation, measurement, commonly documented protocol ranges, and storage for a Tirzepatide 40mg vial.
1. Preparation and Measurement
Tirzepatide 40mg With 2mL of Diluent
Add 2mL of bacteriostatic water to the vial. The resulting concentration is 20mg/mL. On a U-100 syringe, each unit contains 200mcg.
Preparation
- Draw 2mL of bacteriostatic water using sterile equipment.
- Let the liquid run slowly down the inside wall of the vial.
- Gently swirl until dissolved. Do not shake.
- Label with the preparation date and refrigerate.
Check the calculation with the peptide calculator.
2. Commonly Documented Schedule
Route commonly described: subcutaneous in approved comparator products. Frequency: once weekly.
| Period | Documented amount | Measurement |
|---|---|---|
| Weeks 1-4 | 2.5mg once weekly | 0.125mL / 12.5 units |
| Weeks 5-8 | 5mg once weekly | 0.25mL / 25 units |
| Weeks 9-12 | 7.5mg once weekly | 0.375mL / 37.5 units |
| Weeks 13-16 | 10mg once weekly | 0.5mL / 50 units |
| Weeks 17-20 | 12.5mg once weekly | 0.625mL / 62.5 units |
| Weeks 21+ | 15mg once weekly | 0.75mL / 75 units |
Vial estimate: One 40mg vial contains approximately 16 administrations at the first listed amount or 2 at the final listed amount.
Practical Notes
- The table applies only to this vial prepared with exactly 2mL.
- Record the amount, date, and preparation used.
3. Supplies Needed
- Tirzepatide 40mg vial.
- 2mL of bacteriostatic water per vial.
- Sterile U-100 syringes.
- Alcohol swabs.
- Sharps container.
4. Storage and Handling
- Keep unopened vials cool, dry, dark, and protected from moisture.
- After preparation, refrigerate at 2-8 degrees C.
- Protect from light and avoid repeated freeze-thaw cycles.
- Do not use material with particles, discoloration, or a damaged seal.
5. Research Context
Tirzepatide is the active molecule in approved prescription products with indication-specific titration, contraindications, warnings, and device instructions.
The table documents the approved weight-management escalation pattern as a comparator. A laboratory vial is not an approved drug product and is not interchangeable with a regulated injector.